Morgan Stanley raised the firm’s price target on Fresenius Medical (FMS) to EUR 39 from EUR 37 and keeps an Underweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical Care Divests Laboratory Assets to Quest Diagnostics
- Fresenius Medical divesting select laboratory assets to Quest Diagnostics
- Is FMS a Buy, Before Earnings?
- Fresenius Medical price target raised to EUR 46.50 from EUR 41 at Citi
- Fresenius Medical price target raised to EUR 55 from EUR 47 at Berenberg
Questions or Comments about the article? Write to editor@tipranks.com